Cochlear implants case resurfaces in Spain
This article was originally published in Clinica
Executive Summary
Spain's National Confederation for the Deaf (CNSE) has begun a series of meetings with the Health Ministry in order for it to be "urgently updated" on the extent of the risks posed by cochlear implants. Its action in seeking the talks followed it "hearing by chance" about Ministry warnings issued six months ago regarding this type of device. The CNSE has expressed its indignation at the lack of information provided to the wider public about the risks associated with the Clarion and other implants, to which four deaths and six cases of meningitis had been linked in Spain.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.